Organism name | Hyacinthus orientalis |
---|---|
Genus | Hyacinthus |
Family | Hyacinthaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Hyacinthus orientalis |
---|---|
Linked NCBI taxonomy ID | 82025 |
Linked level | species |
Family in NCBI taxonomy | Hyacinthaceae |
---|---|
ID | 44985 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | Liliopsida |
---|---|
ID | 4447 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00006764
![]() |
Pelargonidin 3-glucoside-5-(6'''-malonylglucoside)
|
No. 1 | No. 15 |
![]() |
||||
C00004468
![]() |
Tricin 7-rutinoside-4'-glucoside
|
No. 5 | No. 15 |
![]() |
||||
C00006773
![]() |
Pelargonidin 3-(6''-p-coumarylglucoside)-5-(4'''-malonylglucoside)
|
No. 7 | No. 15 |
![]() |
||||
C00014852
![]() |
Pelargonidin 3-[6-((Z)-p-coumaroyl)glucoside]-5-glucoside
|
No. 7 | No. 15 |
![]() |
||||
C00006767
![]() |
Bisdemalonylsalvianin
|
No. 7 | No. 15 |
![]() |
||||
C00006769
![]() |
Pelargonidin 3-(6''-ferulylglucoside)-5-glucoside
|
No. 7 | No. 15 |
![]() |
||||
C00006772
![]() |
Pelargonidin 3-(6''-p-coumarylglucoside)-5-(6'''-acetylglucoside)
|
No. 7 | No. 15 |
![]() |
||||
C00006777
![]() |
Monardaein
|
No. 7 | No. 15 |
![]() |
||||
C00006775
![]() |
Monodemalonylsalvianin
|
No. 7 | No. 15 |
![]() |
||||
C00006887
![]() |
Monodemalonylsalviadelphin
/ Delphinidin 3-[6-(caffeoylglucoside)]-5-[6-(malonylglucoside)] |
No. 7 | No. 15 |
![]() |
||||
C00014816
![]() |
Delphinidin 3-(6-(Z)-p-coumaroylglucoside)-5-(6-malonylglucoside)
|
No. 7 | No. 15 |
![]() |
||||
C00006899
![]() |
Petunidin 3-(6''-p-coumarylglucoside)-5-(6'''-malonylglucoside)
|
No. 7 | No. 15 |
![]() |
||||
C00006824
![]() |
Malonylshisonin
|
No. 7 | No. 15 |
![]() |
||||
C00006884
![]() |
Awobanin
/ Delphinidin-3-(6-O-p-coumarylglucoside)-5-glucoside |
No. 7 | No. 15 |
![]() |
||||
C00006776
![]() |
Palargonidin 3-(6''-ferulylglucoside)-5-(6'''-malonylglucoside)
|
No. 7 | No. 15 |
![]() |
||||
C00006800
![]() |
Hyacinthin
/ Cyanidin 3-(6-O-p-coumarylglucoside) |
No. 30 | No. 15 |
![]() |
||||
C00036713
![]() |
alpha-Homomannojirimycin
/ (+)-alpha-Homomannojirimycin |
CHEMBL87169
CHEMBL320116 CHEMBL327137 CHEMBL501355 CHEMBL1169500 CHEMBL2093079 CHEMBL2093897 CHEMBL2111688 CHEMBL2114210 CHEMBL2115215 |
C093741
|
6 / 9 / 8 | No. 667 |
![]() |
||
C00002037
![]() |
DMDP
/ (+)-2,5-Dideoxy-2,5-imino-D-mannitol / 2R,5R-Dihydroxymethyl-3R,4R-dihydroxy-pyrrolidine |
CHEMBL10437
CHEMBL312653 CHEMBL121093 CHEMBL259905 CHEMBL405957 CHEMBL469844 CHEMBL2008021 |
C043121
|
8 / 10 / 8 | No. 667 |
![]() |
||
C00036798
![]() |
beta-Homomannojirimycin
|
CHEMBL87169
CHEMBL320116 CHEMBL327137 CHEMBL501355 CHEMBL1169500 CHEMBL2093079 CHEMBL2093897 CHEMBL2111688 CHEMBL2114210 CHEMBL2115215 |
6 / 9 / 8 | No. 667 |
![]() |
|||
C00029420
![]() |
1-Deoxynojirimycin
/ (+)-1-Deoxynojirimycin |
CHEMBL11510
CHEMBL65131 CHEMBL307429 CHEMBL84844 CHEMBL110458 CHEMBL369297 CHEMBL179085 CHEMBL176206 CHEMBL179130 CHEMBL179347 CHEMBL179409 CHEMBL176021 CHEMBL369046 CHEMBL176209 CHEMBL368121 CHEMBL175901 CHEMBL1337303 |
D017485
|
33 / 27 / 27 | No. 786 | No. 1 |
![]() |
|
C00002035
![]() |
1-Deoxymannojirimycin
/ (-)-Deoxymannojirimycin |
CHEMBL11510
CHEMBL65131 CHEMBL307429 CHEMBL84844 CHEMBL110458 CHEMBL369297 CHEMBL179085 CHEMBL176206 CHEMBL179130 CHEMBL179347 CHEMBL179409 CHEMBL176021 CHEMBL369046 CHEMBL176209 CHEMBL368121 CHEMBL175901 CHEMBL1337303 |
33 / 27 / 27 | No. 786 | No. 1 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P04062 | Glucosylceramidase | Enzyme | C00002035 C00002037 C00029420 C00036713 C00036798 | 6 / 4 |
O43451 | Maltase-glucoamylase, intestinal | Hydrolase | C00002035 C00002037 C00029420 C00036713 C00036798 | 0 / 0 |
P06280 | Alpha-galactosidase A | Enzyme | C00002035 C00002037 C00029420 C00036713 C00036798 | 1 / 1 |
P04066 | Tissue alpha-L-fucosidase | Enzyme | C00002035 C00002037 C00029420 C00036713 C00036798 | 1 / 2 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00002035 C00002037 C00029420 C00036713 C00036798 | 1 / 1 |
Q9H227 | Cytosolic beta-glucosidase | Enzyme | C00002035 C00002037 C00029420 | 0 / 0 |
P35573 | Glycogen debranching enzyme | Enzyme | C00002035 C00002037 C00029420 | 1 / 1 |
Q14697 | Neutral alpha-glucosidase AB | Enzyme | C00002035 C00002037 C00029420 | 0 / 0 |
O00462 | Beta-mannosidase | Enzyme | C00002035 C00029420 | 1 / 2 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00002035 C00029420 | 3 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002035 C00029420 | 0 / 1 |
Q8TET4 | Neutral alpha-glucosidase C | Enzyme | C00036713 C00036798 | 0 / 0 |
P23458 | Tyrosine-protein kinase JAK1 | Jakb | C00002035 C00029420 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00002035 C00029420 | 0 / 0 |
P14410 | Sucrase-isomaltase, intestinal | Enzyme | C00002035 C00029420 | 1 / 1 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002035 C00029420 | 1 / 0 |
Q13133 | Oxysterols receptor LXR-alpha | NR1H3 | C00002035 C00029420 | 0 / 0 |
P16278 | Beta-galactosidase | Enzyme | C00002035 C00029420 | 4 / 6 |
Q9HCG7 | Non-lysosomal glucosylceramidase | Enzyme | C00002035 C00029420 | 1 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002035 C00029420 | 0 / 0 |
P55055 | Oxysterols receptor LXR-beta | NR1H3 | C00002035 C00029420 | 0 / 0 |
P09848 | Lactase-phlorizin hydrolase | Enzyme | C00002035 C00029420 | 1 / 1 |
Q16739 | Ceramide glucosyltransferase | Transferase | C00002035 C00029420 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00002035 C00029420 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002035 C00029420 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002035 C00029420 | 0 / 1 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00002035 C00029420 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00002035 C00029420 | 0 / 0 |
O43280 | Trehalase | Enzyme | C00002035 C00029420 | 0 / 0 |
O00754 | Lysosomal alpha-mannosidase | Enzyme | C00002035 C00029420 | 1 / 2 |
Q6P4F1 | Alpha-(1,3)-fucosyltransferase 10 | Enzyme | C00002035 C00029420 | 0 / 0 |
Q9Y2E5 | Epididymis-specific alpha-mannosidase | Enzyme | C00002035 C00029420 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00002035 C00029420 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002035 C00029420 | 1 / 2 |
OMIM | preferred title | UniProt |
---|---|---|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#301500 | Fabry disease |
P06280
|
#230000 | Fucosidosis |
P04066
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#232300 | Glycogen storage disease ii |
P10253
|
#232400 | Glycogen storage disease iii |
P35573
|
#230500 | Gm1-gangliosidosis, type i |
P16278
|
#230600 | Gm1-gangliosidosis, type ii |
P16278
|
#230650 | Gm1-gangliosidosis, type iii |
P16278
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#223000 | Lactase deficiency, congenital |
P09848
|
#248500 | Mannosidosis, alpha b, lysosomal; mansa |
O00754
|
#248510 | Mannosidosis, beta a, lysosomal; mansb |
O00462
|
#253010 | Mucopolysaccharidosis type ivb |
P16278
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#614409 | Spastic paraplegia 46, autosomal recessive; spg46 |
Q9HCG7
|
#222900 | Sucrase-isomaltase deficiency, congenital; csid |
P14410
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00140 | beta-Mannosidosis |
O00462
(related)
|
H00422 | Glycoproteinoses |
O00462
(related)
O00754 (related) P04066 (related) P16278 (related) |
H00139 | alpha-Mannosidosis |
O00754
(related)
|
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
P16278 (related) |
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00141 | Fucosidosis |
P04066
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00116 | Congenital lactase deficiency |
P09848
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
P35573 (related) |
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00115 | Congenital sucrase-isomaltase deficiency |
P14410
(related)
|
H00123 | Mucopolysaccharidosis type IV (MPS4) |
P16278
(related)
|
H00276 | Galactosialidosis |
P16278
(related)
|
H00281 | GM1 gangliosidosis |
P16278
(related)
|
H00421 | Mucopolysaccharidosis (MPS) |
P16278
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|